Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Correction to: Nature Immunology https://doi.org/10.1038/s41590-023-01739-z, published online 15 January 2024. In the version of the article initially published, in the “BCG-induced CX3CR1hi T cells are effector memory T cells” section, the first five callouts to Fig. 3 erroneously cited Fig. 2. This has now been amended in the HTML and PDF versions of the article. About this article Tran, K.A., Pernet, E., Sadeghi, M. et al.
Abstract After a century of using the Bacillus Calmette–Guérin (BCG) vaccine, our understanding of its ability to provide protection against homologous (Mycobacterium tuberculosis) or heterologous (for example, influenza virus) infections remains limited. Here we show that systemic (intravenous) BCG vaccination provides significant protection against subsequent influenza A virus infection in mice.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
